Published on in Vol 8, No 4 (2019): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/12045, first published .
The Effect of Vitamin D Supplements on Clinical and Para-Clinical Outcomes in Patients With Multiple Sclerosis: Protocol for a Systematic Review

The Effect of Vitamin D Supplements on Clinical and Para-Clinical Outcomes in Patients With Multiple Sclerosis: Protocol for a Systematic Review

The Effect of Vitamin D Supplements on Clinical and Para-Clinical Outcomes in Patients With Multiple Sclerosis: Protocol for a Systematic Review

Journals

  1. Ghajarzadeh M, Azimi A, Valizadeh Z, Sahraian M, Mohammadifar M. Efficacy and safety of rituximab in treating patients with multiple sclerosis (MS): A systematic review and meta-analysis. Autoimmunity Reviews 2020;19(8):102585 View
  2. Ghajarzadeh M, Mohammadi A, Sahraian M. Risk of cancer in multiple sclerosis (MS): A systematic review and meta-analysis. Autoimmunity Reviews 2020;19(10):102650 View
  3. Mirmosayyeb O, Barzegar M, Nehzat N, Shaygannejad V, Sahraian M, Ghajarzadeh M. The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis. Journal of Clinical Neuroscience 2020;79:33 View
  4. Azimi A, Hanaei S, Sahraian M, Mohammadifar M, Ramagopalan S, Ghajarzadeh M. Age at menarche and risk of multiple sclerosis (MS): a systematic review and meta-analysis. BMC Neurology 2019;19(1) View
  5. Hanaei S, Sahraian M, Mohammadifar M, Ramagopalan S, Ghajarzadeh M. Effect of Vitamin D supplements on relapse rate and Expanded Disability Status Scale (EDSS) in multiple sclerosis (MS): A systematic review and meta-analysis. International Journal of Preventive Medicine 2021;12(1):42 View